TOPOKINE THERAPEUTICS
Allergan is a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth. Driving continued innovation and growth is the combined company’s strong commitment to R&D, with an investment of ~$1.7 billion in... 2015, focused on strategic development of innovative and durable value-enhancing products within brands, generics, biologics and OTC portfolios. The Company’s Generics portfolio features more than 1,000 generics, branded generics, established brands and OTC products. The Company is the third largest generic manufacturer in the U.S. and holds a top 5 leadership position in nearly 20 International markets. Allergan has global headquarters in Dublin, Ireland and U.S. Administrative Headquarters in Parsippany, New Jersey, USA.
TOPOKINE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2010-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.topokinetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
617-203-2034
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Facebook Sharer Sectigo SSL Sectigo Domain SSL CloudFront Google Adsense AdBlock Acceptable Ads
Founder
Investors List
Schooner Capital
Schooner Capital investment in Venture Round - Topokine Therapeutics
Official Site Inspections
http://www.topokinetherapeutics.com
- Host name: 104.247.82.53
- IP address: 104.247.82.53
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Topokine Therapeutics"
Topokine Therapeutics - Crunchbase Company Profile …
Apr 2, 2014 Topokine Therapeutics is located in Boston, Massachusetts, United States. Who invested in Topokine Therapeutics? Topokine Therapeutics is funded by Schooner Capital. When was the last funding round for Topokine …See details»
Topokine Company Profile 2024: Valuation, Investors ... - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20170202852-A1: Topical dosage regimen: Active: 27-Jun-2014: US-10188661-B2See details»
Topokine Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Topokine Therapeutics, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»
Topokinetherapeutics.com - Overview, News & Similar companies ...
Topokinetherapeutics.com is a company that operates in the Pharmaceuticals industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in the United …See details»
Topokine Therapeutics Inc - Company Profile and News
Topokine Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company develops non-invasive therapies for dermatology and medical aesthetics, such as a topical …See details»
Topokine Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Topokine Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials.See details»
Topokine Therapeutics - Company Profile - Tracxn
Sep 6, 2024 Topokine Therapeutics ranks 98th among 152 active competitors. 51 of its competitors are funded while 50 have exited. Overall, Topokine Therapeutics and its …See details»
Topokine Therapeutics Company Profile -Sales, Contacts, …
Topokine Therapeutics, Inc. (trade name Topokine) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number. Enter company …See details»
Topokine Therapeutics - VentureRadar
Topokine Therapeutics VentureRadar profile. Find out more about Topokine Therapeutics, Topicals.See details»
TOPOKINE THERAPEUTICS, INC. Boston MA, 02111 - Company …
Free Business profile for TOPOKINE THERAPEUTICS, INC. at 60 South St, Boston, MA, 02111-5103, US. TOPOKINE THERAPEUTICS, INC. specializes in: Pharmaceutical Preparations. …See details»
Topokine Therapeutics - Products, Competitors, Financials, …
Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin cream …See details»
Allergan Acquires Topical Dermatology Company Topokine …
Apr 21, 2016 Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program -- Adds global rights to XAF5, potential …See details»
Allergan Announces Acquisition Of Topokine Therapeutics, …
Apr 22, 2016 Allergan plc (NYSE: AGN ) announced on Thursday it has entered into an agreement to acquire Topokine Therapeutics, a privately held, clinical-stage biotechnology …See details»
Allergan makes $85m move for Topokine and under-eye bag drug
Allergan is still on the acquisition trail following its failed merger with Pfizer, spending $85 million to acquire privately-held Topokine Therapeutics and its late-stage product for under-eye bags.See details»
Allergan Acquires Topical Dermatology Company Topokine …
Apr 21, 2016 (NYSE: AGN), a leading global pharmaceutical company, today announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company …See details»
Development of Topical Fat-Burning Gel XAF5 Advances
Jan 28, 2013 Topokine Therapeutics, a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics, has announced a financing arrangement …See details»
Allergan acquires Topokine and undereye bag product rights
Apr 25, 2016 Allergan, a global pharmaceutical company, has acquired Topokine Therapeutics, a biotechnology company that primarily develops topical products for fat reduction, for $85m. …See details»
Ireland’s Allergan acquires US manufacturer Topokine Therapeutics
Apr 24, 2016 Irish pharmaceutical giant Allergan has acquired Topokine Therapeutics, a US-based manufacturer of topical medicines for fat reduction, in a deal valued at $85m. Free …See details»
Allergan Acquires Topokine Therapeutics for $85M Upfront
Apr 22, 2016 Allergan has acquired Topokine Therapeutics for $85 million upfront in a deal that expands the buyer’s cosmetic drugs pipeline with Topokine’s Phase IIb/III candidate XAF5, a …See details»
Late-Stage Trial Initiated for Topical Reduction of Undereye Bags
Jan 7, 2016 Biotechnology company Topokine Therapeutics has initiated a Phase 2b/3 study of its lead product, XAF5 Ointment, for the reduction of steatoblepharon (undereye bags). …See details»